JKAP correlates with lower disease risk and inflammation, and its increment during etanercept treatment associates with commendable treatment efficiency in rheumatoid arthritis patients

CONCLUSIONS: JKAP correlates with reduced disease risk and inflammation, and its increment during ETN treatment associates with commendable treatment efficiency in RA patients.PMID:33829452 | DOI:10.26355/eurrev_202103_25429

Source: European Review for Medical and Pharmacological Sciences - April 8, 2021 Category: Drugs & Pharmacology Authors: X-Y Mou D Jin Q Zhang J-T Guan Y Jin Source Type: research